Oligomerix

United States
Sherburn, Minnesota, United States, 10461

Company profile

Oligomerix company profile

Oligomerix is a biopharmaceutical company founded in 2006 by co-founders Eliot J. Davidowitz and James Moe. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neurodegenerative diseases.

Business identity

Contact email
[email protected]
Phone number
(212) 568-0365
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2006-01-01, Year

Headquarters

Postal code
10461
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
9
Total equity funding
$7.9M
Last funding
Grant / $500,000 / 2025-11-18
Last equity funding
Series B / $2.7M
Investors
6
Lead investors
3
Founders
2
Articles
12

Founders and investors

Founders

Eliot J. DavidowitzJames Moe

Lead investors

National Institute on AgingNational Institutes of HealthSmall Business Innovation Research

Investors

Durand Venture AssociatesNational Institute on AgingNational Institutes of HealthSmall Business Innovation ResearchWheatley Partners